{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:48:49Z","timestamp":1792586929763,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1190830"],"award-info":[{"award-number":["1190830"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013928","name":"Instituto Milenio en Inmunolog\u00eda e Inmunoterapia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008736","name":"Fondo de Fomento al Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["11E1098"],"award-info":[{"award-number":["11E1098"]}],"id":[{"id":"10.13039\/501100008736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009610","name":"Pontificia Universidad Cat\u00f3lica de Chile","doi-asserted-by":"publisher","award":["PCT\/US2008\/076682"],"award-info":[{"award-number":["PCT\/US2008\/076682"]}],"id":[{"id":"10.13039\/501100009610","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.eclinm.2020.100517","type":"journal-article","created":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T20:27:19Z","timestamp":1601929639000},"page":"100517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial"],"prefix":"10.1016","volume":"27","author":[{"given":"Katia","family":"Abarca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Rey-Jurado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Mu\u00f1oz-Durango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaneisi","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A.","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2046-7882","authenticated-orcid":false,"given":"Nicol\u00e1s M.S.","family":"G\u00e1lvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Vald\u00e9s-Ferrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Iturriaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Urz\u00faa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Borzutzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Cerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Villarroel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Madrid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo A.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 V.","family":"Gonz\u00e1lez-Aramundiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7622-5263","authenticated-orcid":false,"given":"Alexis M.","family":"Kalergis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2020.100517_bib0001","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2020.100517_bib0002","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virusres.2011.09.020","article-title":"Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years","volume":"162","author":"Collins","year":"2011","journal-title":"Virus Res"},{"key":"10.1016\/j.eclinm.2020.100517_bib0003","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2174\/187152612800100099","article-title":"The burgeoning burden of respiratory syncytial virus among children","volume":"12","author":"Breese Hall","year":"2012","journal-title":"Infect Disord \u2013 Drug Targets"},{"key":"10.1016\/j.eclinm.2020.100517_bib0004","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3389\/fncel.2018.00386","article-title":"Neurologic alterations due to respiratory virus infections","volume":"12","author":"Bohmwald","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.eclinm.2020.100517_bib0005","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3390\/v12060637","article-title":"Innate immune components that regulate the pathogenesis and resolution of hRSV and hMPV Infections","volume":"12","author":"Andrade","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.eclinm.2020.100517_bib0006","doi-asserted-by":"crossref","first-page":"8132","DOI":"10.1128\/JVI.02699-09","article-title":"Respiratory syncytial virus-neutralizing monoclonal antibodies motavizumab and palivizumab inhibit fusion","volume":"84","author":"Huang","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.eclinm.2020.100517_bib0007","doi-asserted-by":"crossref","first-page":"7394","DOI":"10.1016\/j.vaccine.2017.09.092","article-title":"Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics","volume":"37","author":"Vekemans","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2020.100517_bib0008","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1016\/j.vaccine.2011.01.087","article-title":"et al. Local innate and adaptive immune responses regulate inflammatory cell influx into the lungs after vaccination with formalin inactivated RSV","volume":"29","author":"Kruijsen","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2020.100517_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1004757","article-title":"RSV Vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets","volume":"11","author":"Knudson","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.eclinm.2020.100517_bib0010","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.eclinm.2020.100517_bib0011","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1046\/j.1365-2249.2000.01297.x","article-title":"Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry","volume":"121","author":"Bendelja","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.eclinm.2020.100517_bib0012","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1128\/CVI.00609-15","article-title":"Brief history and characterization of enhanced respiratory syncytial virus disease","volume":"23","author":"Acosta","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.eclinm.2020.100517_bib0013","series-title":"RSV vaccine and mAb Snapshot","first-page":"1","year":"2020"},{"key":"10.1016\/j.eclinm.2020.100517_bib0014","doi-asserted-by":"crossref","first-page":"20822","DOI":"10.1073\/pnas.0806244105","article-title":"Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG","volume":"105","author":"Bueno","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.eclinm.2020.100517_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001012","article-title":"The BCG World atlas: a database of global BCG vaccination policies and practices","volume":"8","author":"Zwerling","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.eclinm.2020.100517_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17370","article-title":"Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Gu\u00e9rin vaccination against tuberculosis","volume":"17","author":"Abubakar","year":"2013","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.eclinm.2020.100517_bib0017","first-page":"635","article-title":"Timing and dose of BCG vaccination in infants as assessed by postvaccination tuberculin sensitivity","volume":"32","author":"Aggarwal","year":"1995","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.eclinm.2020.100517_bib0018","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.4049\/jimmunol.163.4.2249","article-title":"Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination","volume":"163","author":"Marchant","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.eclinm.2020.100517_bib0019","doi-asserted-by":"crossref","first-page":"7633","DOI":"10.4049\/jimmunol.0903452","article-title":"Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus calmette-guerin promotes virus clearance and protects from infection","volume":"185","author":"Cautivo","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.eclinm.2020.100517_bib0020","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.vaccine.2016.12.048","article-title":"A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice","volume":"35","author":"C\u00e9spedes","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2020.100517_bib0021","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.3389\/fimmu.2018.02875","article-title":"Recombinant BCG vaccines reduce pneumovirus-caused airway pathology by inducing protective humoral immunity","volume":"9","author":"Soto","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.eclinm.2020.100517_bib0022","first-page":"391","article-title":"Declaraci\u00f3n de Helsinki","volume":"137","author":"Valdespino G\u00f3mez","year":"2001","journal-title":"Gac Med Mex"},{"key":"10.1016\/j.eclinm.2020.100517_bib0023","first-page":"1","article-title":"Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials","volume":"1","year":"2007","journal-title":"Guid Ind"},{"key":"10.1016\/j.eclinm.2020.100517_bib0024","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/1743-422X-9-253","article-title":"An improved respiratory syncytial virus neutralization assay based on the detection of green fluorescent protein expression and automated plaque counting","volume":"9","author":"van Remmerden","year":"2012","journal-title":"Virol J"},{"key":"10.1016\/j.eclinm.2020.100517_bib0025","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3349\/ymj.2016.57.1.88","article-title":"Comparative evaluation of several gene targets for designing a multiplex-PCR for an early diagnosis of extrapulmonary tuberculosis","volume":"57","author":"Raj","year":"2016","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.eclinm.2020.100517_bib0026","first-page":"155","article-title":"Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10","volume":"7","author":"van Pinxteren","year":"2000","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.eclinm.2020.100517_bib0027","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.vaccine.2016.03.100","article-title":"Adverse reactions to the Bacillus Calmette-Gu\u00e9rin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial","volume":"34","author":"Nissen","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2020.100517_bib0028","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1203\/00006450-200209000-00009","article-title":"Natural reinfection with respiratory syncytial virus does not boost virus-specific T-cell immunity","volume":"52","author":"Bont","year":"2002","journal-title":"Pediatr Res"},{"key":"10.1016\/j.eclinm.2020.100517_bib0029","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/infdis\/163.4.693","article-title":"Immunity to and frequency of reinfection with respiratory syncytial virus","volume":"163","author":"Hall","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eclinm.2020.100517_bib0030","doi-asserted-by":"crossref","first-page":"e5934","DOI":"10.1371\/journal.pone.0005934","article-title":"Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A","volume":"4","author":"Whelan","year":"2009","journal-title":"PLoS One"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537020302613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537020302613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:53:47Z","timestamp":1778903627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537020302613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":30,"alternative-id":["S2589537020302613"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2020.100517","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2020.100517","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100517"}}